- A patient-centric approach and the patient benefits of oral drug delivery of peptides
- Current development challenges
- Outcome of current oral drug delivery technologies
- Why have so few technologies reached the market?
- Science based selection process of drug delivery technology
- What the future holds?
Alan S. Harris, Senior VP, Global R&D Life Cycle Management, Ferring